Ray Boffey will be at Babraham Research Campus this Thursday. Come along to the Cambridge Building if you would like to meet him and find out how #Domainex's integrated drug discovery services could accelerate your research project.
#DrugDiscovery
Scientists whose first language is not English spend much longer to read and write papers in English and prepare for international conferences. @tatsuya_amano and colleagues worked to measure this invisible struggle. I wrote about their work for @Nature https://t.co/18cCZjWQh9
#Domainex is delighted to announce the launch of its #cryo-EM service. This offering expands our structural biology capabilities and complements X-ray crystallography. We have an experienced team and would love to hear from you if you want to learn more.
https://t.co/3bfOKO6MIj
Prepping for a class session on the Lac operon in Molecular Biology and it prompts my yearly reminder to you all that what we were taught about the actual substrate of the Lac operon is almost certainly wrong...1
1/52
I am looking at the young mother lying on the hospital bed
She's shivering & the fever is high
Her liver functions are climbing
Her baby girl is waiting back home
Her father is troubled
I'm faced with an unknown foe, tiny, yet so powerful, it nearly broke me.
Nearly.
I still don’t understand what a drug-protein hydrophobic interaction actually is. I’ll make sure that this poorly defined, collection of interactions is as well defined as more orthodox interactions in my MedChem course. https://t.co/Zt4WLQGrd2
The original paper that established the amyloid plaque model as the foundation of Alzheimer’s research over the last 16 years might not just be wrong, but a deliberate fraud. https://t.co/rkPeFqaVCW
Good news !
Our article titled "The longitudinal dynamics and natural
history of clonal haematopoiesis" has just been published onlline. It has been joyous to work with Marga, Jose, Moritz and our collaborators on this exciting story! Thank you all ! https://t.co/h1K4kaz5Lk
A new paper by @DanNomura et al. describes the development of heterobifunctional molecules analogous to PROTACs capable of targeted protein stabilization, known as deubiquitinase-targeting chimeras (DUBTACs) - find out more in our latest research highlight https://t.co/oJb7KPa2To
'No matter what you work on, if you follow the question, then you will end up in a great place.'
In conversation with Edwige Moyroud: https://t.co/DuP42AKbY0